Literature DB >> 2881445

Progressive supranuclear palsy: anatomoclinical and biochemical considerations.

Y Agid, F Javoy-Agid, M Ruberg, B Pillon, B Dubois, C Duyckaerts, J J Hauw, J C Baron, B Scatton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2881445

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  12 in total

Review 1.  Progressive supranuclear palsy.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

2.  A comparative immunohistochemical study on striatal Met-enkephalin expression in Alzheimer's disease and in progressive supranuclear palsy.

Authors:  S Matsumoto; S Goto; A Hirano
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  A case of progressive supranuclear palsy with widespread senile plaques.

Authors:  S Sasaki; S Maruyama; C Toyoda
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

4.  Current and future treatments in progressive supranuclear palsy.

Authors:  Irene van Balken; Irene Litvan
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.598

5.  Increased wave P 300 latency in progressive supranuclear palsy.

Authors:  C Pierrot-Deseilligny; E Turell; C Penet; D Lebrigand; B Pillon; F Chain; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

Review 6.  Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.

Authors:  D W Dickson
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

7.  Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.

Authors:  E C Hirsch; A M Graybiel; C Duyckaerts; F Javoy-Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Allocortical neurofibrillary changes in progressive supranuclear palsy.

Authors:  H Braak; K Jellinger; E Braak; J Bohl
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.

Authors:  J Epelbaum; F Javoy-Agid; E Hirsch; J J Hauw; C Kordon; S Krantic; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

10.  Behavioral abnormalities in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Kevin Duff; Benjamin Mast; Irene Litvan
Journal:  Psychiatry Res       Date:  2013-09-12       Impact factor: 3.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.